28 February 2019
Surgical Innovations Group plc
("Surgical Innovations" or "the Company")
Exercise of Options & Total Voting Rights
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces that it has today issued and allotted a total of 5,000,000 ordinary shares of 1 penny each in the capital of the Company following an exercise of options by certain employees of the Company. Application will be made to the London Stock Exchange for admission of the 5,000,000 ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading will commence on AIM on 6 March 2019.
Total Voting Rights
Following Admission, the Company will have 787,566,177 ordinary Shares in issue with each share carrying the right to one vote. The Company has no ordinary Shares held in treasury. The total number of voting rights in the Company following Admission will therefore be 787,566,177.
For further information contact:
Surgical Innovations Group Plc |
|
Nigel Rogers, Executive Chairman |
Tel: +44 (0)113 230 7597 |
Melanie Ross, COO and CFO |
|
|
|
Walbrook PR (Financial PR & Investor Relations) |
Tel: +44 (0)20 7933 8780 or si@walbrookpr.com |
Paul McManus |
Mob: +44 (0)7980 541 893 |
Lianne Cawthorne |
Mob: +44 (0)7584 391 303 |
|
|
N+1 Singer (Nominated Adviser and Broker) |
+44 (0)20 7496 3000 |
Richard Lindley |
|
Rachel Hayes |
|